These effects, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the strategy of focusing on ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-similar Issues. Take note: Outcomes may change https://torreyz062vmb7.ja-blog.com/profile